Carla David

Dr. Carla David

University of the Andes, Mérida, Venezuela
+1
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Open access
PDF file
CDCarla David
Carla David
JSJaqueline F. de Souza
Jaqueline F. de Souza
ASAdriana F. Silva
Adriana F. Silva
GGGuillermo Grazioli
Guillermo Grazioli
ABAndressa S. Barboza
Andressa S. Barboza
RMRafael R. Moraes
Rafael R. Moraes
In this study, poly (lactic-co-glycolic acid) (PLGA) microparticles loaded with cannabidiol (CBD) were synthesized (PLGA@CBD microparticles) and embedded up to 10 wt% in a chondroitin sulfate/polyvinyl alcohol hydrogel matrix. In vitro chemical, physical, and biological assays were carried out to validate the potential use of the modified hydrogels as biomaterials. The microparticles had spherical morphology and a narrow range of size distribution. CBD encapsulation efficiency was around 52%, loading was approximately 50%. Microparticle addition to the hydrogels caused minor changes in their morphology, FTIR and thermal analyses confirmed these changes. Swelling degree and total porosity were reduced in the presence of microparticles, but similar hydrophilic and degradation in phosphate buffer solution behaviors were observed by all hydrogels. Rupture force and maximum strain at rupture were higher in the modified hydrogels, whereas modulus of elasticity was similar across all materials. Viability of primary human dental pulp cells up to 21 days was generally not influenced by the addition of PLGA@CBD microparticles. The control hydrogel showed no antimicrobial activity against Staphylococcus aureus, whereas hydrogels with 5% and 10% PLGA@CBD microparticles showed inhibition zones. In conclusion, the PLGA@CBD microparticles were fabricated and successfully embedded in a hydrogel matrix. Despite the hydrophobic nature of CBD, the physicochemical and morphological properties were generally similar for the hydrogels with and without the CBD-loaded microparticles. The data reported in this study suggested that this original biomaterial loaded with CBD oil has characteristics that could enable it to be used as a scaffold for tissue/cellular regeneration. Graphical Abstract

17 October 2022 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
CDCarla David
Carla David
AHAlejandro Elizalde Hernandez
Alejandro Elizalde Hernandez
Andressa da Silva BarbozaAndressa da Silva Barboza
Andressa da Silva Barboza
GCGabriela C. Cardoso
Gabriela C. Cardoso
MSMateus B. F. Santos
Mateus B. F. Santos
RMRafael R. Moraes
Rafael R. Moraes
Cannabidiol (CBD) has been gaining increased attention in contemporary society but seems to have been little explored in dentistry. This scoping review mapped the scientific and technological scenarios related to the use of CBD in dentistry. Peer-reviewed publications were searched in five international databases, patents were searched in five technological platforms. In total, 11 articles and 13 patents involving CBD in dentistry-related applications were included. The countries contributing to most articles were Brazil (27.3%) and USA (18.2%). The studies involved experiments on animals (63.6%) and/or using bacteria or cells (36.4%), and no clinical study was found. Three different applications of CBD were observed: periodontal therapy (45.4%), aid for bone regeneration (27.3%), and general use in oral therapies (27.3%). Patent inventors were based in China (53.8%) or USA (46.2%). The patent claims were mainly compositions for oral care, tooth whitening, injury repair, antifungal, anti-inflammatory, and analgesic effects. A total of 76.9% of the patents were filed in association with a company. In general, research suggests that CBD has promising biological properties for applications in dentistry, whereas patents indicate that the current interest of industry relies on compositions for oral care. There appears to be extensive room available for research and technological applications of CBD in dentistry.

28 September 2020 in Journal of Biomedical Materials Research Part A
Verified
Journal Article
Closed access
PDF file
GGGuillermo Grazioli
Guillermo Grazioli
ASAdriana Fernandes da Silva
Adriana Fernandes da Silva
JSJaqueline F. Souza
Jaqueline F. Souza
CDCarla David
Carla David
LDLisiane Diehl
Lisiane Diehl
RMRafael R. Moraes
Rafael R. Moraes

8 February 2025 in Polymers
Verified
Journal Article
Open access
PDF file
AHAlejandro Elizalde Hernandez
Alejandro Elizalde Hernandez
NBNatalia Link Bahr
Natalia Link Bahr
MBMatheus Coelho Blois
Matheus Coelho Blois
Carlos Cuevas-SuárezCarlos Cuevas-Suárez
Carlos Cuevas-Suárez
EVANDRO PIVAEVANDRO PIVA
EVANDRO PIVA
Rafael Guerra LundRafael Guerra Lund
Rafael Guerra Lund
Soft-tissue expansion is a critical challenge in regenerative oral surgeries. This scoping review maps the research on polymers used in osmotic self-inflating expanders, assessing their applications, characteristics, and potential in oral surgical procedures. The study analyzed 19 articles from the PubMed, Scopus, Web of Science, and Embase databases, primarily focusing on in vivo research (78.9%) investigating polymeric tissue expanders. The review examined polymer compositions, methodologies, and tissue responses across various animal models. Osmed® hydrogel was the most studied material, with research exploring its expansion capabilities in rabbits, goats, pigs, rats, and beagle dogs. The findings showed diverse tissue expansion ranges and minimal inflammatory responses, indicating the potential for oral surgical applications. Despite promising results, gaps such as inconsistent expansion measurements and the lack of standardized protocols were identified. These findings highlight the need for further research to develop new polymer formulations and optimize device design to enhance safety, efficacy, and clinical predictability. This review provides a foundation for advancing polymeric tissue expander technologies, offering the potential for safer and more effective minimally invasive regenerative oral surgeries.

6 November 2025 in Dentistry Journal
Verified
Journal Article
Open access
PDF file
MMMatias Mederos
Matias Mederos
AHAlejandro Elizalde Hernandez
Alejandro Elizalde Hernandez
AFAlejandro A.F. Francia
Alejandro A.F. Francia
LCLuiz Alexandre Chisini
Luiz Alexandre Chisini
CICristina Pereira Isolan
Cristina Pereira Isolan
CDCarla David
Carla David
Background/Objectives: The use of cannabidiol (CBD) as an antimicrobial and antifungal agent has gained interest in medicine, with studies suggesting potential against various microorganisms. However, its effectiveness against oral pathogens remains underexplored in dental research, highlighting the need for further studies. This scoping review summarizes current evidence on the antimicrobial properties of CBD in dental and oral health. Methods: A systematic search was conducted across seven databases (PubMed, the Cochrane Library, Scopus, Embase, Web of Science, SciELO, and LILACS) up to January 2025. The inclusion criteria encompassed studies that explored the effects of CBD on oral microbiology (in vitro and in vivo in animal models), regardless of language or year of publication. The gray literature was evaluated in the Google Scholar database. Results: A total of 1284 articles were identified, of which 10 met the inclusion criteria for this scoping review. These studies, published between 2019 and 2025, primarily focused on bacterial and fungal cultures. The most commonly used methods were the minimum inhibitory concentration test and counting colony-forming units. The contact methods between CBD and bacterial/fungal cell cultures were either dilution or direct contact. Conclusions: CBD shows promising antimicrobial properties against a range of oral bacteria and fungi, suggesting its potential application in managing oral health conditions.

19 May 2020 in OSF Preprints
Verified
Preprint
Open access
CDCarla David
Carla David
AEAlejandro Elizalde
Alejandro Elizalde
The CBD has many reports of pharmacological effects in various models of pathologies, ranging from inflammatory and neurodegenerative diseases, epilepsy, autoimmune disorders such as multiple sclerosis, arthritis, schizophrenia among others (1). In other medical areas has been developing CBD as great therapeutic possibilities, with much research in pre-clinical phases (laboratory tests), reviews about complex diseases of the oral cavity (2) and expression of endocannabinoids receptors in the dental and periodontal tissues (3,4). However, the use of CBD in the dental field has been poorly studied and limited, and its effects in the treatment of oral diseases are not well known and reported. Similarly, knowing its properties, mechanisms of action and favorable results in the treatment of other oral diseases, it is believed that it may have a positive therapeutic effect in some pathologies of CBD therapeutic dentistry based on scientific publications that discuss its mechanism of treatment action, suggesting possibilities for future investigations on the use of this compound in dentistry in previous years. Therefore, the purpose of this scoping review will be to map the available evidence to provide an overview and technology of the use of cannabidiol, its effects, and related products in dentistry.References.1.PISANTI, Simona, et al. Cannabidiol: State of the art and new challenges for therapeutic applications. Pharmacology & therapeutics, vol. 175, p. 133-150, 2017. DOI: https://doi.org/10.1016/j.pharmthera.2017.02.041. 2.CUBA, L. F., et al. Cannabidiol: an alternative therapeutic agent for oral mucositis?. Journal of clinical pharmacy and therapeutics, 2017, vol. 42, no 3, p. 245-250.3. Abidi, Ammaar H., et al. "Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts." Archives of oral biology 87 (2018): 79-85.4.KONERMANN, Anna, et al. In vivo and in vitro identification of endocannabinoid signaling in periodontal tissues and their potential role in local pathophysiology. Cellular and molecular neurobiology, 2017, vol. 37, no 8, p. 1511-1520.